<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T11:02:56Z</responseDate>
  <request identifier="oai:figshare.com:article/33776147" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33776147</identifier>
        <datestamp>2026-09-15T07:40:44Z</datestamp>
        <setSpec>category_37339</setSpec>
        <setSpec>category_37354</setSpec>
        <setSpec>portal_1012</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary Tables1 from The Novel Hypomethylating Agent NTX-301 Reprograms Epigenetic and Hippo Signaling Pathways and Exhibits Preclinical Activity in Venetoclax-Resistant and &lt;i&gt;TP53&lt;/i&gt;-Mutant AML</dc:title>
          <dc:creator>Bing Z. Carter (15088381)</dc:creator>
          <dc:creator>Po Yee Mak (24915956)</dc:creator>
          <dc:creator>Suresh Satpati (24915959)</dc:creator>
          <dc:creator>Edward Ayoub (24317652)</dc:creator>
          <dc:creator>Steffen Boettcher (21460551)</dc:creator>
          <dc:creator>Lauren B. Ostermann (24915962)</dc:creator>
          <dc:creator>Yue Wei (24223566)</dc:creator>
          <dc:creator>Guillermo Garcia-Manero (14855106)</dc:creator>
          <dc:creator>Torsten Haferlach (21631183)</dc:creator>
          <dc:creator>Kunal Rai (15056365)</dc:creator>
          <dc:creator>Michael Andreeff (14855635)</dc:creator>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Molecular and Cellular Biology</dc:subject>
          <dc:subject>Cell Death And Senescence</dc:subject>
          <dc:subject>Apoptosis</dc:subject>
          <dc:subject>Caspases</dc:subject>
          <dc:subject>bcl-2 pathways</dc:subject>
          <dc:description>&lt;p&gt;Supplementary Tables&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1158/1078-0432.33776147</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_Tables1_from_The_Novel_Hypomethylating_Agent_NTX-301_Reprograms_Epigenetic_and_Hippo_Signaling_Pathways_and_Exhibits_Preclinical_Activity_in_Venetoclax-Resistant_and_i_TP53_i_-Mutant_AML/33776147</dc:relation>
          <dc:rights>CC BY</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
